http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20120011169-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a6928a4722175b6afaf60db3754437c7 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-322 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-324 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-344 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7028 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L29-035 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-344 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 |
| filingDate | 2010-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2d8c0e0101a0e4aa6d63b13c4083d0f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d67ef1fcfbfe6907165e0d007642917f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_014211bf31359b74c32f7721d16c399a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6dc98c5a4a47536d024fd7fac6fe5074 |
| publicationDate | 2012-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20120011169-A |
| titleOfInvention | Composition for the treatment or prevention of cancer or human immunodeficiency virus (HIB) |
| abstract | The present invention is Lansemaside A, Lansemaside X, Ikanocyst acid 3- O- β-D-glucuronopyranoside, Ikanocyst acid, Compound K, Actigenin, Actinin, Naringenin, Gin Cenosides Rh1, Ginsenoside Rh2, Carlophanax saponin A, Tengeretin, Nobiletine, Apigenin, Camperol, Deodeok Extract, Haedongpi Extract, Ginseng Extract, Ginseng Fermentation, Allium Extract, and / or Allium Ferment Compositions for the treatment (improvement) or prevention of HIV infectious diseases, AIDS, HIV dementia, and / or HIV neuronal damage, lansemaside A, icanocyst acid 3- O- β-D-glucu Cancer treatment (improvement) or preventive composition containing lanofyranoside, icanoinosist acid, actin, carlophanax saponin A, deodeok extract, thaw skin extract, and / or allium extract as an active ingredient, lanceemaside A, Compound K, Deodeok Extract, and / or PI3K inhibitors, Lancemaside A, Compound K, Actigenin, Deodeok Extract, Ginseng Fermentation and / or AKT Activation Inhibitor, Actigenin and / or Allium Fermentation Containing Hemp Fermentation It provides a GSK3 beta activator containing an allied fermented product as an active ingredient. The active ingredients in the compositions, inhibitors and / or activators of the present invention may be used for the treatment and / or prevention of cancer, HIV infection, AIDS, HIV dementia, or HIV neuronal damage, inhibition of AKT activation, inhibition of PI3K and / or GSK3. Effective for beta activation |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023172034-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019098787-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160024092-A |
| priorityDate | 2010-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 139.